Abstract:Purpose: Recent animal studies suggest that activation of Wnt/β-catenin signaling in articular chondrocytes might be a driving factor in the pathogenesis of osteoarthritis (OA) by stimulating amongst others the expression of matrix metalloproteinases (MMPs). Indeed in animal chondrocytes IL-1β induced MMP expression is mediated by activation of canonical Wnt/β-catenin signaling. This study aimed to investigate the role of Wnt/β-catenin signaling in IL-1β induced MMP expression in human chondrocytes. Methods: Primary cultures of human articular chondrocytes derived from post mortem healthy donors or patients with end stage osteoarthritis or rheumatoid arthritis were used in all experiments. Cells were stimulated with recombinant growth factors and cytokines. Changes in gene and protein expression were studied using qPCR, Western blot, and enzymatic essays. Multiple strategies for activation and inhibition of signaling pathways in human chondrocytes, such as lentiviral mediated gene overexpression or gene knock down were used. Luciferase reporter assays and co-immunoprecipitation essays were used to study the interaction between β-catenin and NF-κB. Results: IL-1β potently stimulated MMP1, -3 and -13 expression in human and murine chondrocytes dose-dependently. In marked contrast, co-stimulation with the recombinant Wnt3A, which activates canonical Wnt/β-catenin signaling, potently inhibited IL-1β induced MMP dose-dependently in human chondrocytes but not in murine chondrocytes. This inhibitory effect was found in human chondrocytes irrespective of the disease state of the donor being either healthy, osteoarthritic or rheumatoid arthritic and was also found in human bone marrow derived mesenchymal stem cells. In contrast, Wnt/β-catenin signaling induced MMP expression in chondrocytes of all animal species tested, revealing an unprecedented species difference. Wnt3A's inhibitory effect was found in both basal conditions and after IL-1β stimulation at the mRNA level, protein level and in enzymatic essays. Wesetern blot indicated that IL-1β indirectly activated β-catenin in human chondrocytes. This was due to IL-1β induced upregulation of the canonical Wnt7B and down regulation of the Wnt-signaling antagonists DKK1, Wif1 and FRZb as demonstrated by gene knock down and gene overexpression studies. The inhibitory effect of Wnt3A on IL-1β induced MMP expression was independent of TCF/LEF transcription factors, since knock down of TCF4 did not alter Wnt3A's effect. This was in marked contrast to murine chondrocytes in which knock down of TCF4 completely blocked IL-1β induced MMP expression. Subsequently, we showed that the inhibitory effect on IL-1β induced MMP expression in human chondrocytes was due to an inhibitory protein-protein interaction between β-catenin and NF-κB/p65RELA blocking the activation of NF-κB promoter reporter constructs as well as inhibiting the expression of established NF-κB target genes like IL-6. Conclusions: Our study reveals an unexpected and unprecedented species difference between human and animal chondrocytes with respect of the role of Wnt/β-catenin signaling in the regulation of MMP expression. In marked contrast to mouse chondrocytes in which Wnt/β-catenin signaling is part of an IL-1β activated pro-catabolic sequence resulting in increased MMP expression, in human cells β-catenin has an unexpected anti-catabolic role. We provide evidence that Wnt/β-catenin signaling is part of an IL-1β activated negative feedback loop involving upregulation of the canonical Wnt7B and down regulation of established Wnt-antagonists like DKK1. This leads to activation of β-catenin, which in turn inhibits NF-κB activity due to an inhibitory protein-protein interaction with p65RELA. Our results question the relevance of animal models for studying the role of Wnt/β-catenin signaling in osteoarthritis. They furthermore imply that upregulated β-catenin in human osteoarthritic cartilage may be part of an anti-catabolic response counteracting pro-catabolic NF-κB signaling.

NEAT1-mediated miR-150-5p downregulation regulates b-catenin expression in OA chondrocytes

Downregulation of Lncrna NEAT1 Interacts with Mir-374B-5p/pgap1 Axis to Aggravate the Development of Osteoarthritis.

LncRNA NEAT1 regulates chondrocyte proliferation and apoptosis via targeting miR-543/PLA2G4A axis

Long Noncoding RNA Nuclear Enriched Abundant Transcript 1 (NEAT1) Regulates Proliferation, Apoptosis, and Inflammation of Chondrocytes via the miR-181a/Glycerol-3-Phosphate Dehydrogenase 1-Like (GPD1L) Axis

NEAT1/miR-181c Regulates Osteopontin (OPN)-Mediated Synoviocyte Proliferation in Osteoarthritis.

LncRNA NEAT1 Promotes Proliferation of Chondrocytes Via Down‐regulation of Mir‐16‐5p in Osteoarthritis

Wnt/β‑catenin Signaling May Induce Senescence of Chondrocytes in Osteoarthritis

MicroRNA-140-5p represses chondrocyte pyroptosis and relieves cartilage injury in osteoarthritis by inhibiting cathepsin B/Nod-like receptor protein 3

MicroRNA-1 Modulates Chondrocyte Phenotype by Regulating FZD7 of Wnt/ β-Catenin Signaling Pathway

Long non-coding RNA KCNQ1OT1 promotes cell viability and migration as well as inhibiting degradation of CHON-001 cells by regulating miR-126-5p/TRPS1 axis

Downregulated Microrna‐106 Inhibits Apoptosis and Promotes Proliferation and Differentiation of Chondrocytes in Osteoarthritis Through Restraining the Activation of Wnt/β‐catenin Pathway

A WNT/β-catenin Negative Feedback Loop Inhibits IL-1β Induced Mmp Expression in Human Articular Chondrocytes

Circular RNA circ_0128846 promotes the progression of osteoarthritis by regulating miR-127-5p/NAMPT axis

MicroRNA-377–3p Alleviates IL-1β-caused Chondrocyte Apoptosis and Cartilage Degradation in Osteoarthritis in Part by Downregulating ITGA6

Mechanosensitive lncRNA H19 promotes chondrocyte autophagy, but not pyroptosis, by targeting miR-148a in post-traumatic osteoarthritis

Circular RNA Related to the Chondrocyte ECM Regulates MMP13 Expression by Functioning As a MiR-136 ‘sponge’ in Human Cartilage Degradation

MicroRNA-486 Promotes a More Catabolic Phenotype in Chondrocyte-Like Cells by Targeting SIRT6 POSSIBLE INVOLVEMENT IN CARTILAGE DEGRADATION IN OSTEOARTHRITIS

Inhibition of Beta-Catenin Signaling in Articular Chondrocytes Results in Articular Cartilage Destruction

Long noncoding RNA related to cartilage injury promotes chondrocyte extracellular matrix degradation in osteoarthritis.

LncRNA LEMD1-AS1 relieves chondrocyte inflammation by targeting miR-944/PGAP1 in osteoarthritis

LINC00623/miR-101/HRAS Axis Modulates IL-1β-mediated ECM Degradation, Apoptosis and Senescence of Osteoarthritis Chondrocytes.